Physiology
New physiology study findings have been reported from Eli Lilly and Company
Published in Obesity and Diabetes Week, September 8th, 2008
New research, 'Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582,' is the subject of a report. "An analog of the trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine series (LY255582) exhibits high in vitro binding affinity and antagonist potency for the mu-, delta-, and kappa-opioid receptors. In vivo, LY255582 exhibits potent effects in reducing food intake and body weight in several rodent models of obesity," scientists writing in the American Journal of Physiology - Regulatory, Integrative and Comparative Physiology report.
"In the present study, we evaluated the effects...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Canadian Medical Association Journal
Low cholesterol associated with cancer in diabetics - Columbia University's Mailman School of Public Health
Health risk behaviors associated with lower prostate specific antigen awareness - Temple University
Not all fat is created equal - University of Tennessee at Knoxville
New findings explain genetic disorder's unique shift - Cardiovascular Disease
New cardiovascular disease study results from F.M.R. Sanches et al described - Kidney Disease
New kidney disease study findings recently were reported by researchers at Children's Hospital - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
